Xueyan Li

4PUBLICATIONS
19CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|Sep 02, 2025
Screening Candidates for Conversion Therapy in Unresectable Hepatocellular Carcinoma Patients After Tyrosine Kinase Inhibitor Plus PD-1/PD-L1 Antibody Therapy: A Multicenter Retrospective Study.

Zhe Jin, Xueyan Li, Ling Lv

|Jun 25, 2025
Radiomic Model Associated with Tumor Microenvironment Predicts Immunotherapy Response and Prognosis in Patients with Locoregionally Advanced Nasopharyngeal Carcinoma.

Jie Sun, Xuewei Wu, Xiao Zhang

|Oct 01, 2019
Correlation between 18F-FDG maximum standardized uptake value with CD147 expression in lung adenocarcinomas: a retrospective study.

Fei Guo, Xueyan Li, Guodong Yao

|May 31, 2019
Prognostic and Predictive Values of Metabolic Parameters of 18F-FDG PET/CT in Patients With Non-Small Cell Lung Cancer Treated With Chemotherapy.

Xueyan Li, Dawei Wang, Lijuan Yu

Pageof 1

Frequent Collaborators

2 joint publications

Xuewei Wu

2 joint publications

Zhe Jin

1 joint publications

Jie Sun

1 joint publications

Xiao Zhang